Weight Loss Tablets Available in Australia
Prescribed weight loss tablets can provide excellent results for people who are trying to lose weight. These tablets boost weight loss along with proper diet and constant exercise. In Australia, three common weight loss tablets are safe and available to use.
Duromine has been in the market for more than 50 years already, and the results are promising. It is an amphetamine component, and it is a good appetite suppressant. This means that the person taking these tablets feel less hungry. It also includes close monitoring from your physician. Common side effects of taking Duromine include dry mouth, headaches, insomnia, restlessness, nervousness, agitation, fast heartbeat, high blood pressure and, rarely, psychosis and hallucinations.
Contrave (Bupropion and Naltrexone)
Contrave is the newest contender when it comes to weight loss tablets available in Australia. This weight loss medication targets an area of the brain that suppresses appetite and controls energy use. Just like other medications, Contrave is preferred taken along with reduced calorie-diet and physical activities. Nausea, vomiting, constipation, stomach pain, headache, and dizziness are some of the common side effects patients feel when taking Contrave.
Orlistat inhibits lipase in the gut. This results in reduced absorption of fat up to 30%. The reduced absorption of the body makes the person lose their weight. The remaining fat will pass through the gut and excreted. Maintaining a low-fat diet is the best approach when taking this pill. If too much fat is consumed, oily rectal leakage and fatty bowel movements are some of the side effects. The bowel movement changes are an alert to the patient to keep their diet low in fat. The patient should have the discipline to change eating habits.
Semaglutide 1mg is a GLP-1 agonist that was available for treatment of type 2 diabetes from July 2020. Semaglutide is a once-weekly injection that powerfully suppresses appetite. The most common side effects are nausea, constipation, reflux, diarrhoea, headache and fatigue. Studies are emerging on the use of Semaglutide 2.4mg for the treatment obesity and it is expected that this treatment will be available sometime in 2022.
However, Semaglutide is not yet registered by the TGA (Therapeutic Goods Administration) in Australia as a weight management agent. It is currently approved for use in diabetes only. For more information about Semaglutide (Ozempic), check this cheat sheet we have for you.
While each pill works well with many people, it is still advised that patients talk to their doctors first before getting themselves the medication. Talk to us in Alevia. We are a team of bariatric experts that can help you choose your weight loss medication. Book an appointment now and talk with one of our experts today.